Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ADVM


Fundamental

Company: Adverum Biotechnologies Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: -
P/E: -
EPS (ttm): -7.85
Insider Own: 34.02%
Shs Outstand: 20.98M
Perf Week: 0.47%
Market Cap: 90.65M
Forward P/E: -
EPS next Y: -2.73
Insider Trans: -0.18%
Shs Float: 13.85M
Perf Month: -18.80%
Enterprise Value: 138.47M
PEG: -
EPS next Q: -1.75
Inst Own: 45.90%
Short Float: 6.32%
Perf Quarter: 92.86%
Income: -164.28M
P/S: 90.65
EPS this Y: 6.26%
Inst Trans: -14.10%
Short Ratio: 1.51
Perf Half Y: 53.74%
Sales: 1.00M
P/B: -
EPS next Y Percentage: 55.98%
ROA: -93.88%
Short Interest: 0.88M
Perf YTD: -7.49%
Book/sh: -0.96
P/C: 2.04
EPS next 5Y: 22.83%
ROE: -222.28%
52W High: 8.18 -47.19%
Perf Year: -44.04%
Cash/sh: 2.12
P/FCF: -
EPS past 3/5Y: 23.61% 8.03%
ROIC: -254.14%
52W Low: 1.78 142.70%
Perf 3Y: -48.68%
Dividend Est.: -
EV/EBITDA: -
Sales past 3/5Y: -48.91% 31.95%
Gross Margin: -191.80%
Volatility W: 1.81%
Volatility M: 6.95%
Perf 5Y: -96.19%
Dividend TTM: -
EV/Sales: 138.47
EPS Y/Y TTM: 1.80%
Oper. Margin: -17441.50%
ATR (14): 0.27
Perf 10Y: -94.88%
Dividend Ex-Date: -
Quick Ratio: 1.54
Sales Y/Y TTM: -72.22%
Profit Margin: -16427.50%
RSI (14): 51.08
Recom: 2.00
Dividend Gr. 3/5Y: - -
Current Ratio: 1.54
EPS Q/Q: -164.26%
SMA20: 0.15%
Beta: 0.86
Target Price: 9.90
Payout: -
Debt/Eq: -
Sales Q/Q: -
SMA50: 5.25%
Rel Volume: 0.51
Prev Close: 4.28
Employees: 155
LT Debt/Eq: -
Earnings: Aug 12 BMO
SMA200: 24.07%
Avg Volume: 578.05K
Price: 4.32
IPO: Jul 31, 2014
Option/Short: Yes / Yes
EPS/Sales Surpr.: -4.15% -
Trades:
Volume: 294,449
Change: 0.93%

Technical:


Latest News:

Analysts' Top Healthcare Picks: Adverum Biotechnologies (ADVM), Gilead Sciences (GILD) somewhat bullish
ADVM GILD CVRX

Summary: Analysts are bullish on Adverum Biotechnologies (ADVM), Gilead Sciences (GILD), and CVRx (CVRX) in the Healthcare sector.

Full article
2025-02-13T15:11:42Z